TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT01028313

A Study of Panobinostat (LBH589) as Second-Line Therapy in Patients With Chronic Graft-Versus-Host Disease

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“A decision was made to not move forward with the study. No participants were enrolled or treated.”

The sponsor’s own words in the registry.

Life of this trial

200920102011201220132014Registered2009-12-07Withdrawn (as of)2013-02-13

Vital statistics

Status
Withdrawn
Phase
Phase 2
Sponsor
SCRI Development Innovations, LLC
Sponsor type
University, hospital or other
Conditions
Chronic Graft-Versus-Host Disease
Interventions
LBH589; Methylprednisolone
Participants
0
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.